DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by) has announced the addition of the "Vaccine Market by Technology, Type, End User, Disease Indication - Forecasts to 2019" report to their offering.
Vaccine Market by Technology (Live Attenuated, Toxoid, Conjugate, Subunit, Synthetic, Dendritic Cell, Inactivated), Type (Preventive, Therapeutic), End User (Pediatrics, Adults), Disease Indication (Infectious Disease, Cancer, Allergy) - Forecasts to 2019
The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. For the purposes of this report the global vaccines market is categorized on the basis of type, technology, disease indication, end user, and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market, by type, during the forecast period. Its favorable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.
Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development, and rising initiatives by non-government organizations for vaccinations. Furthermore, government support in the form of funding is another major factor providing impetus for growth of this market. For instance, in November 2014, the U.K. government granted $2 billion (£1.32 billion) to GAVI for the improvement of immunization programs in poor countries.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Vaccines Market, By Technology
8 Vaccines Market, By Type
9 Vaccines Market, By Disease Indication
10 Vaccines Market, By End User
11 Global Vaccine Technology Market, By Region
12 Competitive Landscape
13 Company Profiles
- Bavarian Nordic
- CSL Limited
- Emergent Biosolutions, Inc.
- Glaxosmithkline, PLC.
- Johnson & Johnson
- Medimmune, LLC. (A Subsidiary of Astrazeneca)
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
For more information visit http://www.researchandmarkets.com/research/mcbchq/vaccine_market_by